MedPage Today September 18, 2023
Judy George

— Privacy policies, terms of sale often are unclear

Direct-to-consumer (DTC) laboratory tests — for the thyroid, hormonal biomarkers, or diabetes and hemoglobin A1c, for example — often had unclear terms of sale and vague privacy policies, a qualitative study showed.

Of 21 U.S. companies that offered DTC lab tests, less than half declared compliance with the Health Insurance Portability and Accountability Act (HIPAA), and less than a quarter specified protections for biological samples, according to Louiza Kalokairinou, PhD, of the Baylor College of Medicine Center for Medical Ethics and Health Policy in Houston, and co-authors.

More than half stated consumer data potentially could be used for research purposes, either internally or through a third party, Kalokairinou and colleagues reported...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

 
Topics: Govt Agencies, Healthcare System, HIPAA, Patient / Consumer, Privacy / Security, Provider
Endometriosis and fertility: What every woman should know
Co-prescribing stimulants and opioids may fuel the twin epidemic of overdose
Journalists Discuss Health Care for Incarcerated Children and the Possibility of a Bird Flu Pandemic
What Is HKU5-CoV-2? Scientists Find Bat Virus Similar To COVID-19
Medicare patients with cancer often receive aggressive treatment over supportive care

Share This Article